Results 1 to 10 of about 6,238,038 (408)
The gut–liver axis and gut microbiota in health and liver disease
Nature Reviews Microbiology, 2023 Bernd Schnabl
exaly +2 more sources
Modern Pathology, 2016 The median waiting time for patients with MELD ≥ 35 decreased from 18 days in 2012 to 9 days in 2014, after implementation of the Share 35 policy in June 2013. Similarly, mortality among candidates listed with MELD ≥ 35 decreased from 366 per 100 waitlist years in 2012 to 315 in 2014.
W R, Kim +10 more
+9 more sources
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Hepatology, 2023 The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language.
M. Rinella +52 more
semanticscholar +1 more source
Current Opinion in Gastroenterology, 1998 Continued discussion over organ allocation and distribution remained a focal point in the field of liver transplantation in the year 2000. Despite the ongoing debate, no significant changes were implemented in the current allocation system. By far, the most widely discussed topic in liver transplantation this year was live donor adult-to-adult liver ...
Brown, KA, Moonka, DK
openaire +6 more sources
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Liver Cancer, 2023 Background: Primary liver cancer, of which around 75–85% is hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the ...
Jian Zhou +101 more
semanticscholar +1 more source
MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease.
Gastroenterology, 2020 Fatty liver associated with metabolic dysfunction is common, affects a quarter of the population, and has no approved drug therapy. While pharmacotherapies are in development, response rates appear modest.
M. Eslam, A. Sanyal, J. George
semanticscholar +1 more source
Journal of Experimental & Clinical Cancer Research, 2020 Background Hepatocellular carcinoma is the third top cause of cancer-related mortalities worldwide. The prognosis of HCC patients remains poor due to rapid progression and high incidence of tumor recurrence.
Hui Li +11 more
doaj +1 more source
Cell Death and Disease, 2023 Multidrug resistance is a major challenge in treating advanced hepatocellular carcinoma (HCC). Although recent studies have reported that the multidrug resistance phenotype is associated with abnormal DNA methylation in cancer cells, the epigenetic ...
Xiao-Jun Guo +17 more
doaj +1 more source
Liver Anatomy: Microcirculation of the Liver [PDF]
Seminars in Interventional Radiology, 2008 Comprehension of the structural and functional characteristics of the hepatic microcirculation can help improve the design, planning, and practice of imaging-guided treatment for hepatic tumors and for portal vein embolization (PVE). The hepatic microcirculation derives dual blood supply from the portal vein and the hepatic artery.
Zuxing Kan, David C. Madoff
openaire +2 more sources
Canadian Journal of Gastroenterology and Hepatology, 2022 Objectives. Factors prognostic of survival in liver transplant (LT) recipients with hepatitis B virus related acute-on-chronic liver failure (HBV-ACLF) remain unclear.
Zhengjun Zhou +6 more
doaj +1 more source